Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target

被引:1
|
作者
Dattani, Abhishek [1 ]
Singh, Anvesha
Mccann, Gerry P.
Gulsin, Gaurav S.
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, England
关键词
diabetes; calcium handling; manganese-enhanced MRI; GLYCATION END-PRODUCTS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; CONGESTIVE-HEART-FAILURE; DIASTOLIC DYSFUNCTION; VENTRICULAR MYOCYTES; CARDIAC STRUCTURE; GENE-EXPRESSION; MANGANESE IONS; YOUNG-ADULTS; CARDIOMYOPATHY;
D O I
10.3390/jcdd11010012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes (T2D) is a multisystem disease with rapidly increasing global prevalence. Heart failure has emerged as a major complication of T2D. Dysregulated myocardial calcium handling is evident in the failing heart and this may be a key driver of cardiomyopathy in T2D, but until recently this has only been demonstrated in animal models. In this review, we describe the physiological concepts behind calcium handling within the cardiomyocyte and the application of novel imaging techniques for the quantification of myocardial calcium uptake. We take an in-depth look at the evidence for the impairment of calcium handling in T2D using pre-clinical models as well as in vivo studies, following which we discuss potential novel therapeutic approaches targeting dysregulated myocardial calcium handling in T2D.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Pyruvate Carboxylase, a Novel Therapeutic Target for Type 2 Diabetes
    Kumashiro, Naoki
    Beddow, Sara A.
    Fat, Ioana
    Majumdar, Sachin K.
    Guebre-Egziabher, Fitsum
    Christianson, Jennifer L.
    Manchem, Prasad
    Monia, Brett P.
    Bhanot, Sanjay
    Shulman, Gerald I.
    Samuel, Varman T.
    DIABETES, 2011, 60 : A460 - A460
  • [2] Novel therapeutic approach to target endothelial dysfunction in type 2 diabetes
    Sena, C. M.
    Pereira, A. M.
    Fernandes, R.
    Santos-Silva, D.
    Faustino, A.
    Ceica, R.
    CARDIOVASCULAR RESEARCH, 2014, 103
  • [3] GPR30 Novel Therapeutic Target for Type 2 Diabetes
    Kumar, Rajesh
    Balhusizen, Alexander
    Salehi, Albert
    DIABETES, 2010, 59 : A444 - A444
  • [4] Dysregulated Myocardial Calcium Handling is a Driver of Early Heart Failure in Type 1 and Type 2 Diabetes
    Joshi, Shruti S.
    Dattani, Abhishek
    Gulsin, Gaurav
    Singh, Trisha
    Kershaw, Lucy
    Yeo, Jian
    Singh, Anvesha
    Brady, Emer
    Spath, Nick
    Parke, Kelly
    Arnold, Jayanth
    Reynolds, Rebecca
    Forbes, Shareen
    Gibb, Fraser
    Williams, Michelle
    Semple, Scott
    Dweck, Marc
    McCann, Gerry
    Newby, David E.
    CIRCULATION, 2022, 146
  • [5] Type 2 ryanodine receptor: A novel therapeutic target in myocardial ischemia/reperfusion
    Fauconnier, Jeremy
    Roberge, Stephanie
    Saint, Nathalie
    Lacampagne, Alain
    PHARMACOLOGY & THERAPEUTICS, 2013, 138 (03) : 323 - 332
  • [6] Type 2 diabetes: ceramides as a therapeutic target?
    Hajduch, Eric
    Bourron, Olivier
    CLINICAL LIPIDOLOGY, 2013, 8 (06) : 607 - 609
  • [7] eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes
    Gao, Lei
    Ramirez, Francisco J.
    Cabrera, Jody Tori O.
    Varghese, Mathews V.
    Watanabe, Makiko
    Tsuji-Hosokawa, Atsumi
    Zheng, Qiuyu
    Yang, Mingya
    Razan, Md Rahatullah
    Kempf, Carrie L.
    Camp, Sara M.
    Wang, Jian
    Garcia, Joe G. N.
    Makino, Ayako
    DIABETOLOGIA, 2024, 67 (09) : 1998 - 2011
  • [8] Molecular therapeutic target for type-2 diabetes
    Chou, KC
    JOURNAL OF PROTEOME RESEARCH, 2004, 3 (06) : 1284 - 1288
  • [9] Therapeutic Approaches to Target Inflammation in Type 2 Diabetes
    Goldfine, Allison B.
    Fonseca, Vivian
    Shoelson, Steven E.
    CLINICAL CHEMISTRY, 2011, 57 (02) : 162 - 167
  • [10] AMPK activation: a therapeutic target for type 2 diabetes?
    Coughlan, Kimberly A.
    Valentine, Rudy J.
    Ruderman, Neil B.
    Saha, Asish K.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 241 - 253